Breast cancer accounts for 11.7% of all cancer cases, and several valuable markers have been advocated, such as estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER2), and Ki67 [2]. This evidence concerns the gene PGR and cancer.